Lewy body dementia: Difference between revisions

The [[Synucleinopathy|synucleinopathies]] ([[dementia with Lewy bodies]], [[Parkinson's disease dementia]], and [[Parkinson's disease]]) are characterized by shared features of [[parkinsonism]] motor symptoms, neuropsychiatric symptoms, impaired cognition, [[sleep disorder]]s, and [[visual hallucination]]s.<ref name=Valayudhan2017>{{cite journal |vauthors=Velayudhan L, Ffytche D, Ballard C, Aarsland D |title=New Therapeutic Strategies for Lewy Body Dementias |journal=Curr Neurol Neurosci Rep |volume=17 |issue=9 |pages=68 |date=September 2017 |pmid=28741230 |doi=10.1007/s11910-017-0778-2 |s2cid=3739100 |type= Review}}</ref><ref name=McKeithConsensus2017>{{cite journal |vauthors=McKeith IG, Boeve BF, Dickson DW, ''et al'' |title=Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium |journal=Neurology |volume=89 |issue=1 |pages=88–100 |date=July 2017 |pmid=28592453 |pmc=5496518 |doi=10.1212/WNL.0000000000004058 |type=Review }}</ref> The Lewy body dementias—[[dementiadementias—dementia with Lewy bodies]] (DLB), and [[Parkinson's disease dementia]] (PDD)—are distinguished by the timing when cognitive and motor symptoms appear.<ref name= Connors2018>{{cite journal |vauthors=Connors MH, Quinto L, McKeith IG, et al|title=Non-pharmacological interventions for Lewy body dementia: a systematic review |journal=Psychol Med |volume=48 |issue=11 |pages=1749–58 |date=August 2018 |pmid=29143692 |pmc=6088773 |doi=10.1017/S0033291717003257 |type= Review}}</ref> The two Lewy body dementias are often considered to belong on a spectrum of Lewy body disease that includes Parkinson's disease.<ref name=Gomperts2016/><ref name=Kon2020/>